✦ LIBER ✦

A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate

✍ Scribed by Milan Zdravkovic; Anette K. Olsen; Tina Christiansen; Rainer Schulz; Mitchell E. Taub; Mikael S. Thomsen; Michael H. Rasmussen; Mapoko M. Ilondo

Publisher: Springer
Year: 2003
Tongue: English
Weight: 236 KB
Volume: 58
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-002-0539-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tofisopam inhibits the pharmacokinetics

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam

✍ Mária Tóth; Sándor Drabant; Bálint Varga; Gyula Végső; Anna Cseh; Imre Szentpéte 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 67 KB

Pioglitazone, an in vitro inhibitor of C

Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide

✍ Lauri I. Kajosaari; Tiina Jaakkola; Pertti J. Neuvonen; Janne T. Backman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 164 KB

Effect of ketoconazole-mediated CYP3A4 i

Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor

✍ Paul Hamberg; Margaret M. Woo; Lin-Chi Chen; Jaap Verweij; Maria Grazia Porro; L 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 285 KB

Delineation of the interactions between

Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4

✍ Z.-Y. Zhang; B. M. King; R. D. Pelletier; Y. N. Wong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 491 KB

Assessment of ifosfamide pharmacokinetic

Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma

✍ Rashmi Chugh; Thomas Wagner; Kent A. Griffith; Jeremy M.G. Taylor; Dafydd G. Tho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract ## BACKGROUND. Ifosfamide is a chemotherapeutic agent that requires cytochrome P450 3A (CYP3A) for bioactivation and metabolism. To the authors' knowledge, the correlation between dose, pharmacokinetics, CYP3A, and toxicity has not been fully evaluated. A randomized Phase II trial was

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)